Loading...
Dermisonics, Inc.
DMSI•PNK
HealthcareMedical - Specialties
$0.00
$0.00(233.33%)
Dermisonics, Inc. (DMSI) Stock Overview
Explore Dermisonics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for DMSIStats details for DMSI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for DMSIAnalyst Recommendations details for DMSI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. It primarily focuses on the development, testing, and commercialization of its active transdermal patch, called the U-Strip, that has been designed to facilitate the needle-free delivery of drugs with large molecular structures, such as Insulin into the bloodstream. The company was formerly known as Second Stage Ventures, Inc. and changed its name to Dermisonics, Inc. in October 2004. Dermisonics, Inc. was founded in 2000 and is based in Irvine, California.
CEO
Mr. Bruce H. Haglund
Founded
2003